Leuven, Belgium, – December 2, 2020. Materialise NV (Nasdaq:MTLS), a global leader in 3D printing solutions, has released SurgiCase software, an online case management system (CMS) for personalized medical devices. The SurgiCase software, will give medical device companies and clinicians a single location to exchange data, communicate about procedural planning and check the status of their cases. This reduces the administrative overhead and ultimately helps these companies to help more patients with a personalized device at a lower cost.
Read more
RSNA Annual Meeting – (Nov. 30, 2020). Materialise NV (Nasdaq: MTLS), a global leader in medical 3D printing software and services, introduced its new Mimics VR Viewer today at the RSNA Annual Meeting, bringing virtual reality (VR) capabilities to its popular 3D modeling platform.
Read more
Leuven, Belgium - November 18, 2020. Materialise NV (Nasdaq: MTLS), a leading company in 3D technology solutions in the industrial and medical markets, announces Bluesint PA12, a material innovation that makes it possible to 3D print with up to 100% re-used powder. 3D printing is often considered a sustainable manufacturing technology but a new Lifecycle Analysis indicates that for large series of identical products, 3D printing has a bigger environmental impact compared to a conventional production technology. With the announcement of Bluesint PA12, Materialise creates a path towards eliminating waste in 3D printing.
Read more
Leuven, Belgium - November 18, 2020. Materialise NV (Nasdaq: MTLS), a leading company in 3D technology solutions in the industrial and medical markets, announces innovations that will help companies scale their 3D printing operations and empower the choice for sustainability.
Read more
Leuven, Belgium - November 10, 2020. Materialise NV (Nasdaq: MTLS), a leading company in 3D technology solutions in the industrial and medical markets, announces it obtained the CE Marking Certification for most of its personalized orthopaedic and cranio-maxillofacial (CMF) solutions. This includes 3D-printed anatomical models and patient-matched surgical guides and implants. Materialise is a pioneer and world leader of personalized solutions, helping patients and surgeons in six continents with the production of over 350,000 personalized devices. The company became one of the first to acquire this kind of certification for a large, personalized, 3D-printed medical device portfolio. This certification will make the technology more accessible for surgeons.
Read more
